Bifidophilus Flora Force

Bifidophilus Flora Force

If a person is healthy, eats right and leads a normal lifestyle, the intestinal flora does not make itself felt. But as soon as one of these components changes, trouble begins. Foreign microorganisms – enterococci, clostridia, staphylococci, yeast-like fungi can be present in a healthy body in small quantities. Their reproduction is prevented by normal intestinal microflora. A change in its qualitative composition leads to a disruption of the microbial balance in the intestines – dysbacteriosis. One of the main reasons for the development of dysbiosis is the recent sharp increase in the consumption of antibiotics, sulfonamides and a number of other drugs. Another reason is stress. The risk group consists of people in a state of constant stress, as well as residents of environmentally unfavorable regions. Weakened immunity, inflammatory diseases of the gastrointestinal tract, food allergies, and inadequate nutrition also lead to the development of dysbiosis. Clinical signs of dysbiosis are increased gas formation, abdominal pain, diarrhea, unstable stool or constipation may develop.

The NSP company has developed the drug Bifidophilus Flora Force NSP, which very gently and naturally restores normal intestinal microflora. It contains Bifidobacterium longum and Lactobacillus acidophilus. Once in the gastrointestinal tract, they easily multiply, displacing and mercilessly dealing with pathogenic microflora, including the causative agents of dysentery and salmonellosis, and also resist the formation of carcinogenic nitroso compounds in the intestines.

Scientists have proven that one of the main factors provoking stomach and duodenal ulcers is the bacterium Helicobacter pylori. And again Bifidobacterium longum and Lactobacillus acidophilus come to the rescue, which inhibit the reproduction of Helicobacter.

Who should take Bifidophilus Flora Force NSP? We recommend it to everyone. This drug is necessary for pregnant and nursing mothers, the elderly, those who suffer from disorders of the gastrointestinal tract, have undergone surgery, or take antibiotics (during the course and 2 weeks later).